|
GNAQ expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.269800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.348960E-01 |
| Normal-vs-Stage2 |
9.492600E-01 |
| Normal-vs-Stage3 |
3.768000E-01 |
| Normal-vs-Stage4 |
4.827000E-01 |
| Stage1-vs-Stage2 |
4.187400E-01 |
| Stage1-vs-Stage3 |
9.758800E-01 |
| Stage1-vs-Stage4 |
9.273000E-01 |
| Stage2-vs-Stage3 |
4.830000E-01 |
| Stage2-vs-Stage4 |
5.199000E-01 |
| Stage3-vs-Stage4 |
9.486800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.921800E-01 |
| Normal-vs-AfricanAmerican |
1.855630E-01 |
| Normal-vs-Asian |
2.242000E-04 |
| Caucasian-vs-AfricanAmerican |
6.415800E-01 |
| Caucasian-vs-Asian |
9.008300E-02 |
| AfricanAmerican-vs-Asian |
4.836100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.483600E-02 |
| Normal-vs-Female |
6.954800E-01 |
| Male-vs-Female |
9.066000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.711800E-02 |
| Normal-vs-Extreme_Weight |
1.108800E-01 |
| Normal-vs-Obese |
6.412200E-01 |
| Normal-vs-Extreme_Obese |
4.175900E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.597400E-01 |
| Normal_Weight-vs-Obese |
5.697900E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.907400E-01 |
| Extreme_Weight-vs-Obese |
8.841700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.395400E-01 |
| Obese-vs-Extreme_Obese |
1.605420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.934400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.498800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.160420E-02 |
| Normal-vs-Age(81-100Yrs) |
4.236900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.537200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.020800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.496000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.997250E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.958700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.125400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.505000E-01 |
| Normal-VS-Type2 PRCC |
2.619100E-03 |
| Normal-VS-KIRP CIMP |
5.084800E-01 |
| Normal-VS-Unclassified PRCC |
8.628400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.315500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.061400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.419000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.053800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.535700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.464800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.767800E-04 |
| Normal-vs-N1 |
8.510400E-01 |
| Normal-vs-N2 |
7.093600E-01 |
| N0-vs-N1 |
2.982300E-02 |
| N0-vs-N2 |
5.178400E-01 |
| N1-vs-N2 |
7.228000E-01 |
|
|
